Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Non-invasive prenatal testing in Germany: a unique ethical and policy landscape

12 Dec 2022

Abstract excerpt

Non-invasive prenatal testing (NIPT) has been available commercially in Europe since approximately 2012. Currently, many countries are in the process of integrating NIPT into their publicly funded healthcare systems to screen for chromosomal aneuploidies such as trisomy 21 (Down syndrome), with a variety of implementation models. In 2019, the German Federal Joint Committee (G-BA), which plays a significant role...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ethics and Legal Issues in Pediatric Healthcare
Share to Prenatal Screening and Diagnostics

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36509835
DOI: 10.1038/s41431-022-01256-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Non-invasive prenatal testing in Germany: a unique ethical and policy landscapePMID 36509835Read ↗

The ethical landscape(s) of non-invasive prenatal testing in England, France and Germany: findings from a comparative literature reviewSemantic proximity Read ↗

Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screeningSemantic proximity Read ↗

Current controversies in prenatal diagnosis 1: should noninvasive DNA testing be the standard screening test for Down syndrome in all pregnant women?Semantic proximity Read ↗

Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Summary and recommendationsSemantic proximity Read ↗

Obstetricians and gynecologists' practice and opinions of expanded carrier testing and noninvasive prenatal testingSemantic proximity Read ↗

A new era in prenatal care: non-invasive prenatal testing in SwitzerlandSemantic proximity Read ↗

A decade of non‐invasive prenatal screening in Australia: National impact on prenatal screening and diagnostic testingSemantic proximity Read ↗

Does non‐invasive prenatal testing affect the livebirth prevalence of Down syndrome in the Netherlands? A population‐based register studySemantic proximity Read ↗

‘Hope for safe prenatal gene tests’. A content analysis of how the UK press media are reporting advances in non‐invasive prenatal testingSemantic proximity Read ↗

Implementing non-invasive prenatal testing for aneuploidy in a national healthcare system: global challenges and national solutionsSemantic proximity Read ↗

Routes to expanded carrier screening in the UK: the perspectives of professional stakeholdersSemantic proximity Read ↗

NIPT: current utilization and implications for the future of prenatal genetic counselingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.